Literature DB >> 3897398

Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.

H M Swingle, R L Bucciarelli, E M Ayoub.   

Abstract

Antimicrobial sensitivity, synergy, and timed-killing assays were determined for 20 strains of group B streptococci isolated from cultures of blood and cerebrospinal fluid (CSF) of infected neonates. The mean minimal inhibitory concentrations by the tube-dilution method were as follows: penicillin, 0.02 microgram/ml; ampicillin, 0.05 microgram/ml; and gentamicin, 4.5 micrograms/ml. No synergy was detected with any combination of penicillin or ampicillin and gentamicin by the checkerboard titration method. Killing kinetics were determined for combinations of penicillin or ampicillin and gentamicin at low concentrations of these antibiotics comparable to those attained in the CSF following systemic administration of these antibiotics. Addition of 0.1 microgram and 0.5 microgram of gentamicin/ml to penicillin or ampicillin significantly accelerated the killing of group B streptococci. Despite the "poor" permeation of gentamicin into the CSF, the accelerated killing of streptococci at low concentrations of this antibiotic provides a rationale for the initial use of a combination of penicillin or ampicillin and gentamicin in the treatment of group B streptococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897398     DOI: 10.1093/infdis/152.3.515

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Pharmacokinetics of penicillin g in very-low-birth-weight neonates.

Authors:  Tuuli Metsvaht; Kersti Oselin; Mari-Liis Ilmoja; Kaili Anier; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

2.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 3.  Chemotherapy for bacterial infections of the central nervous system.

Authors:  N M Ampel; E L Labadie
Journal:  West J Med       Date:  1987-09

Review 4.  Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Authors:  Sagori Mukhopadhyay; Kelly C Wade; Karen M Puopolo
Journal:  Clin Perinatol       Date:  2019-03-30       Impact factor: 3.430

5.  Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.

Authors:  J L Gaillard; C Silly; A Le Masne; B Mahut; F Lacaille; G Cheron; V Abadie; P Hubert; V Matha; C Coustere
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 6.  Group B streptococcal infection in older patients. Spectrum of disease and management strategies.

Authors:  M M Farley
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

7.  Early synergistic killing activity at concentrations attainable in CSF of amoxicillin or cefotaxime and aminoglycosides against Haemophilus influenzae.

Authors:  E Bingen; N Lambert-Zechovsky; Y Aujard; P Mariani; G Lemer; C Sauzeau; H Mathieu
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

8.  Antimicrobial treatment of serious gram-negative infections in newborns.

Authors:  James W Gray; Hirminder Ubhi; Philip Milner
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

9.  Is Penicillin Plus Gentamicin Synergistic against Clinical Group B Streptococcus isolates?: An In vitro Study.

Authors:  Corinne Ruppen; Agnese Lupo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

10. 

Authors:  Y Aujard
Journal:  EMC Pediatr       Date:  2012-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.